Daniel Menéndez
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 5%
- Immunology top 10%
- Biotechnology top 2%
- Co-authors
- Michael A. ResnickAlberto IngaMaria ShatzMichael B. FesslerDouglas A. BellStavros GarantziotisJulie M. LoweJennifer Jordan
- Topics
- Cancer-related Molecular Pathways (20 papers)RNA modifications and cancer (8 papers)Epigenetics and DNA Methylation (7 papers)
- Cited by
- OncologyCancer ResearchBiotechnology
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- United StatesItalyGermany
In The Last Decade
Daniel Menéndez
41 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.4k
- Oncology 1.2k
- Cancer Research 417
- Immunology 390
- Biotechnology 224
Countries citing papers authored by Daniel Menéndez
This map shows the geographic impact of Daniel Menéndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Menéndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Menéndez more than expected).
Fields of papers citing papers by Daniel Menéndez
This network shows the impact of papers produced by Daniel Menéndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Menéndez. The network helps show where Daniel Menéndez may publish in the future.
Co-authorship network of co-authors of Daniel Menéndez
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Menéndez. A scholar is included among the top collaborators of Daniel Menéndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Menéndez. Daniel Menéndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 23 | |
| 3 | 26 | |
| 4 | 23 | |
| 5 | 70 | |
| 6 | 30 | |
| 7 | 5 | |
| 8 | 26 | |
| 9 | 138 | |
| 10 | 59 | |
| 11 | 37 | |
| 12 | 120 | |
| 13 | 21 | |
| 14 | 97 | |
| 15 | Potentiating the p53 network. | 28 |
| 16 | 21 | |
| 17 | 452 | |
| 18 | 35 | |
| 19 | 27 | |
| 20 | Metronidazol: una visión integral | 4 |
About Daniel Menéndez
Daniel Menéndez is a scholar working on Oncology, Biotechnology and Immunology, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (20 papers), RNA modifications and cancer (8 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (417 citations) and Biotechnology (224 citations). Daniel Menéndez has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Michael A. Resnick, Alberto Inga, Maria Shatz, Michael B. Fessler, Douglas A. Bell, Stavros Garantziotis, Julie M. Lowe, Jennifer Jordan, Thuy‐Ai Nguyen and Joyce Snipe. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.